hamburger-icon SHAREHOLDER SERVICES MAJOR SHAREHOLDERS Investors At a Glance Financial Highlights Investment Case CEO Q&A Share Tools Results, Reports and Presentations Financial Calendar Regulatory News Shareholder Services AGM Registrar Services Major Shareholders Advisor Contacts Analyst Coverage Corporate Governance Investor Contacts Sustainability Newsroom SHARE INFORMATION The total number of shares issued is 133,366,726 Ordinary Shares of 0.1 pence each 0.4% of the shares are not in public hands The Clinigen Group Employee Benefit Trust holds 614,807 shares SIGNIFICANT SHAREHOLDERS The following were the significant shareholders as at 31st October 2021 (above 3%). Shareholder % issued share capital Slater Investments 7.06% Janus Henderson Investors 6.08% Octopus Investments 5.66% Rathbones 5.58% Elliott Management 5.16% AXA Framlington Investment Managers 4.48% Invesco 3.65% NFU Mutual 3.36% Allianz Global Investors 3.02% RELATED LINKS ANNUAL REPORT ANNUAL REPORT 2021 Download report (pdf 4.64mb) INVESTORS INVESTMENT CASE Read more SHARE TOOLS SHARE TOOLS View all OUR GLOBAL OFFICES United Kingdom Europe Asia, Pacific and Japan South Africa United States SITE TOOLS Stay In Touch AE Reporting Medical enquiries Terms of use Cookies Privacy policy Privacy Statement for Pharmacovigilance Data UK Gender Pay Gap Report Modern Slavery Statement Access Online Sitemap Consumer Information Obligations Clinigen Terms And Conditions Of Business (Sales) Clinigen Terms And Conditions Of Business (Purchases) Cookie settings FIND A MEDICINE Online services for healthcare professionals Hard to find medicines (Clinigen Direct) Managed Access Programs (Cliniport) Clinigen Products Twitter Linkedin © Copyright 2021 Clinigen Group plc. By Emperor OUR USE OF COOKIES We use cookies to improve your experience. By clicking accept, we will set recommended analytics cookies. AcceptRejectSettings